{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T17:42:50Z","timestamp":1790358170477,"version":"4.1.0"},"reference-count":73,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2014,7,1]],"date-time":"2014-07-01T00:00:00Z","timestamp":1404172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"European Research Council under the European Union\u05f3s Seventh Framework Programme (FP\/2007-2013)\/ERC","award":["311335"],"award-info":[{"award-number":["311335"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Cell Research"],"published-print":{"date-parts":[[2014,7]]},"DOI":"10.1016\/j.yexcr.2014.03.014","type":"journal-article","created":{"date-parts":[[2014,3,28]],"date-time":"2014-03-28T17:55:06Z","timestamp":1396029306000},"page":"10-17","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"title":["Pathophysiology and spectrum of diseases caused by defects in lymphocyte cytotoxicity"],"prefix":"10.1016","volume":"325","author":[{"given":"Marie","family":"Meeths","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel C.C.","family":"Chiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"L\u00f6fstedt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martha-Lena","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bianca","family":"Tesi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan-Inge","family":"Henter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yenan T.","family":"Bryceson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.yexcr.2014.03.014_bib1","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1126\/science.7518614","article-title":"Fas and perforin pathways as major mechanisms of T cell-mediated cytotoxicity","volume":"265","author":"Kagi","year":"1994","journal-title":"Science"},{"key":"10.1016\/j.yexcr.2014.03.014_bib2","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1038\/370650a0","article-title":"Cytolytic T-cell cytotoxicity is mediated through perforin and Fas lytic pathways","volume":"370","author":"Lowin","year":"1994","journal-title":"Nature"},{"key":"10.1016\/j.yexcr.2014.03.014_bib3","doi-asserted-by":"crossref","first-page":"2918","DOI":"10.1182\/blood.V78.11.2918.2918","article-title":"Hypercytokinemia in familial hemophagocytic lymphohistiocytosis","volume":"78","author":"Henter","year":"1991","journal-title":"Blood"},{"key":"10.1016\/j.yexcr.2014.03.014_bib4","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1002\/pbc.21039","article-title":"HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis","volume":"48","author":"Henter","year":"2007","journal-title":"Pediatr. Blood Cancer"},{"key":"10.1016\/j.yexcr.2014.03.014_bib5","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1126\/science.286.5446.1957","article-title":"Perforin gene defects in familial hemophagocytic lymphohistiocytosis","volume":"286","author":"Stepp","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.yexcr.2014.03.014_bib6","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/0092-8674(95)90013-6","article-title":"Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome","volume":"81","author":"Fisher","year":"1995","journal-title":"Cell"},{"key":"10.1016\/j.yexcr.2014.03.014_bib7","doi-asserted-by":"crossref","first-page":"e35","DOI":"10.1182\/blood-2010-04-280347","article-title":"Revised diagnostic criteria and classification for the autoimmune lymphoproliferative syndrome (ALPS): report from the 2009 NIH International Workshop","volume":"116","author":"Oliveira","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.yexcr.2014.03.014_bib8","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S0092-8674(03)00855-9","article-title":"Munc13-4 is essential for cytolytic granules fusion and is mutated in a form of familial hemophagocytic lymphohistiocytosis (FHL3)","volume":"115","author":"Feldmann","year":"2003","journal-title":"Cell"},{"key":"10.1016\/j.yexcr.2014.03.014_bib9","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1093\/hmg\/ddi076","article-title":"Linkage of familial hemophagocytic lymphohistiocytosis (FHL) type-4 to chromosome 6q24 and identification of mutations in syntaxin 11","volume":"14","author":"zur Stadt","year":"2005","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.yexcr.2014.03.014_bib10","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.ajhg.2009.09.005","article-title":"Familial hemophagocytic lymphohistiocytosis type 5 (FHL-5) is caused by mutations in Munc18-2 and impaired binding to syntaxin 11","volume":"85","author":"zur Stadt","year":"2009","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.yexcr.2014.03.014_bib11","doi-asserted-by":"crossref","first-page":"3765","DOI":"10.1172\/JCI40732","article-title":"Munc18-2 deficiency causes familial hemophagocytic lymphohistiocytosis type 5 and impairs cytotoxic granule exocytosis in patient NK cells","volume":"119","author":"Cote","year":"2009","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.yexcr.2014.03.014_bib12","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1182\/blood-2007-02-074468","article-title":"Defective cytotoxic lymphocyte degranulation in syntaxin-11 deficient familial hemophagocytic lymphohistiocytosis 4 (FHL4) patients","volume":"110","author":"Bryceson","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.yexcr.2014.03.014_bib13","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1182\/blood-2012-07-442558","article-title":"Comparison of primary human cytotoxic T-cell and natural killer cell responses reveal similar molecular requirements for lytic granule exocytosis but differences in cytokine production","volume":"121","author":"Chiang","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.yexcr.2014.03.014_bib14","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/76024","article-title":"Mutations in RAB27A cause Griscelli syndrome associated with haemophagocytic syndrome","volume":"25","author":"Menasche","year":"2000","journal-title":"Nat.Genet."},{"key":"10.1016\/j.yexcr.2014.03.014_bib15","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1038\/382262a0","article-title":"Identification of the homologous beige and Chediak-Higashi syndrome genes","volume":"382","author":"Barbosa","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.yexcr.2014.03.014_bib16","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1038\/284553a0","article-title":"A new immunodeficiency disorder in humans involving NK cells","volume":"284","author":"Roder","year":"1980","journal-title":"Nature"},{"key":"10.1016\/j.yexcr.2014.03.014_bib17","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/2424","article-title":"Host response to EBV infection in X-linked lymphoproliferative disease results from mutations in an SH2-domain encoding gene","volume":"20","author":"Coffey","year":"1998","journal-title":"Nat. Genet."},{"key":"10.1016\/j.yexcr.2014.03.014_bib18","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/nature05257","article-title":"XIAP deficiency in humans causes an X-linked lymphoproliferative syndrome","volume":"444","author":"Rigaud","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.yexcr.2014.03.014_bib19","doi-asserted-by":"crossref","first-page":"2754","DOI":"10.1182\/blood-2011-08-374199","article-title":"A prospective evaluation of degranulation assays in the rapid diagnosis of familial hemophagocytic syndromes","volume":"119","author":"Bryceson","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.yexcr.2014.03.014_bib20","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1084\/jem.160.3.695","article-title":"Cytolytic T cell granules. Isolation, structural, biochemical, and functional characterization","volume":"160","author":"Podack","year":"1984","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.yexcr.2014.03.014_bib21","doi-asserted-by":"crossref","first-page":"2659","DOI":"10.1182\/blood-2012-07-446146","article-title":"Perforin forms transient pores on the target cell plasma membrane to facilitate rapid access of granzymes during killer cell attack","volume":"121","author":"Lopez","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.yexcr.2014.03.014_bib22","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1182\/blood-2012-07-441832","article-title":"Surface CD107a\/LAMP-1 protects natural killer cells from degranulation-associated damage","volume":"122","author":"Cohnen","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.yexcr.2014.03.014_bib23","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1038\/nri911","article-title":"Functional significance of the perforin\/granzyme cell death pathway","volume":"2","author":"Trapani","year":"2002","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.yexcr.2014.03.014_bib24","doi-asserted-by":"crossref","first-page":"448","DOI":"10.3389\/fimmu.2013.00448","article-title":"Graded defects in cytotoxicity determine severity of hemophagocytic lymphohistiocytosis in humans and mice","volume":"4","author":"Jessen","year":"2013","journal-title":"Front. Immunol."},{"key":"10.1016\/j.yexcr.2014.03.014_bib25","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1038\/ni1000","article-title":"Adaptor protein 3-dependent microtubule-mediated movement of lytic granules to the immunological synapse","volume":"4","author":"Clark","year":"2003","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.yexcr.2014.03.014_bib26","doi-asserted-by":"crossref","first-page":"3879","DOI":"10.1182\/blood-2011-09-382556","article-title":"Terminal transport of lytic granules to the immune synapse is mediated by the kinesin-1\/Slp3\/Rab27a complex","volume":"119","author":"Kurowska","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.yexcr.2014.03.014_bib27","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1038\/ni1431","article-title":"Secretory cytotoxic granule maturation and exocytosis require the effector protein hMunc13-4","volume":"8","author":"Menager","year":"2007","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.yexcr.2014.03.014_bib28","doi-asserted-by":"crossref","first-page":"4117","DOI":"10.1182\/blood-2009-06-225359","article-title":"Different NK cell-activating receptors preferentially recruit Rab27a or Munc13-4 to perforin-containing granules for cytotoxicity","volume":"114","author":"Wood","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.yexcr.2014.03.014_bib29","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1002\/eji.201344011","article-title":"Syntaxin11 serves as a t-SNARE for the fusion of lytic granules in human cytotoxic T lymphocytes","volume":"44","author":"Halimani","year":"2014","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.yexcr.2014.03.014_bib30","doi-asserted-by":"crossref","first-page":"E4482","DOI":"10.1073\/pnas.1313474110","article-title":"Syntaxin binding mechanism and disease-causing mutations in Munc18-2","volume":"110","author":"Hackmann","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"issue":"4","key":"10.1016\/j.yexcr.2014.03.014_bib31","first-page":"e515","article-title":"An N-terminal missense mutation in STX11 causative of FHL4 abrogates syntaxin-11 binding to Munc18-2","volume":"5","author":"M\u00fcller","year":"2014","journal-title":"Front. Immunol."},{"key":"10.1016\/j.yexcr.2014.03.014_bib32","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1182\/blood-2012-07-440339","article-title":"Distinct severity of HLH in both human and murine mutants with complete loss of cytotoxic effectors PRF1, RAB27A, and STX11","volume":"121","author":"Sepulveda","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.yexcr.2014.03.014_bib33","doi-asserted-by":"crossref","first-page":"3520","DOI":"10.1002\/eji.200939378","article-title":"A role for endobrevin\/VAMP8 in CTL lytic granule exocytosis","volume":"39","author":"Loo","year":"2009","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.yexcr.2014.03.014_bib34","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.4049\/jimmunol.1000770","article-title":"The exocytosis of lytic granules is impaired in Vti1b- or Vamp8-deficient CTL leading to a reduced cytotoxic activity following antigen-specific activation","volume":"185","author":"Dressel","year":"2010","journal-title":"J. Immunol."},{"key":"10.1016\/j.yexcr.2014.03.014_bib35","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1038\/ncomms2467","article-title":"Synaptobrevin2 is the v-SNARE required for cytotoxic T-lymphocyte lytic granule fusion","volume":"4","author":"Matti","year":"2013","journal-title":"Nat. Commun."},{"key":"10.1016\/j.yexcr.2014.03.014_bib36","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1182\/blood-2003-10-3413","article-title":"An animal model of hemophagocytic lymphohistiocytosis (HLH): CD8+ T cells and interferon gamma are essential for the disorder","volume":"104","author":"Jordan","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.yexcr.2014.03.014_bib37","doi-asserted-by":"crossref","first-page":"6582","DOI":"10.1182\/blood-2011-01-329607","article-title":"Disruption of MyD88 signaling suppresses hemophagocytic lymphohistiocytosis in mice","volume":"117","author":"Krebs","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.yexcr.2014.03.014_bib38","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1084\/jem.20102538","article-title":"Hemophagocytosis causes a consumptive anemia of inflammation","volume":"208","author":"Zoller","year":"2011","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.yexcr.2014.03.014_bib39","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1002\/art.37958","article-title":"Interferon-gamma mediates anemia but is dispensable for fulminant toll-like receptor 9-induced macrophage activation syndrome and hemophagocytosis in mice","volume":"65","author":"Canna","year":"2013","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.yexcr.2014.03.014_bib40","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/j.immuni.2006.09.010","article-title":"Perforin and granzymes have distinct roles in defensive immunity and immunopathology","volume":"25","author":"van Dommelen","year":"2006","journal-title":"Immunity"},{"key":"10.1016\/j.yexcr.2014.03.014_bib41","doi-asserted-by":"crossref","first-page":"4620","DOI":"10.1182\/blood-2011-05-356113","article-title":"Subtle differences in CTL cytotoxicity determine susceptibility to hemophagocytic lymphohistiocytosis in mice and humans with Chediak-Higashi syndrome","volume":"118","author":"Jessen","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.yexcr.2014.03.014_bib42","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1038\/nature10624","article-title":"Natural killer cells act as rheostats modulating antiviral T cells","volume":"481","author":"Waggoner","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.yexcr.2014.03.014_bib43","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1111\/j.1651-2227.1991.tb11878.x","article-title":"Incidence in Sweden and clinical features of familial hemophagocytic lymphohistiocytosis","volume":"80","author":"Henter","year":"1991","journal-title":"Acta Paediatr. Scand."},{"key":"10.1016\/j.yexcr.2014.03.014_bib44","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1007\/s10875-011-9609-4","article-title":"Newborn screening for severe combined immunodeficiency: the Wisconsin experience (2008\u20132011)","volume":"32","author":"Verbsky","year":"2012","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.yexcr.2014.03.014_bib45","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/j.1365-2141.2008.07315.x","article-title":"Characterization of PRF1, STX11 and UNC13D genotype-phenotype correlations in familial hemophagocytic lymphohistiocytosis","volume":"143","author":"Horne","year":"2008","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.yexcr.2014.03.014_bib46","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1136\/jmg.2010.085456","article-title":"Genotype-phenotype study of familial haemophagocytic lymphohistiocytosis type 3","volume":"48","author":"Sieni","year":"2011","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.yexcr.2014.03.014_bib47","doi-asserted-by":"crossref","first-page":"5794","DOI":"10.1182\/blood-2011-07-370148","article-title":"Hypomorphic mutations in PRF1, MUNC13-4, and STXBP2 are associated with adult-onset familial hemophagocytic lymphohistiocytosis","volume":"118","author":"Zhang","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.yexcr.2014.03.014_bib48","doi-asserted-by":"crossref","first-page":"2635","DOI":"10.1182\/blood-2010-05-282541","article-title":"Spectrum of clinical presentations in familial hemophagocytic lymphohistiocytosis (FHL) type 5 patients with mutations in STXBP2","volume":"116","author":"Meeths","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.yexcr.2014.03.014_bib49","doi-asserted-by":"crossref","first-page":"9809","DOI":"10.1073\/pnas.0903815106","article-title":"Temperature sensitivity of human perforin mutants unmasks subtotal loss of cytotoxicity, delayed FHL, and a predisposition to cancer","volume":"106","author":"Chia","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"10.1016\/j.yexcr.2014.03.014_bib50","doi-asserted-by":"crossref","first-page":"2618","DOI":"10.1182\/blood-2013-06-508143","article-title":"Mixed hematopoietic or T-cell chimerism above a minimal threshold restores perforin-dependent immune regulation in perforin-deficient mice","volume":"122","author":"Terrell","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.yexcr.2014.03.014_bib51","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1146\/annurev-immunol-031210-101324","article-title":"Natural innate and adaptive immunity to cancer","volume":"29","author":"Vesely","year":"2011","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.yexcr.2014.03.014_bib52","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1084\/jem.192.5.755","article-title":"Perforin-mediated cytotoxicity is critical for surveillance of spontaneous lymphoma","volume":"192","author":"Smyth","year":"2000","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.yexcr.2014.03.014_bib53","doi-asserted-by":"crossref","first-page":"4424","DOI":"10.1182\/blood-2004-04-1477","article-title":"A proportion of patients with lymphoma may harbor mutations of the perforin gene","volume":"105","author":"Clementi","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.yexcr.2014.03.014_bib54","doi-asserted-by":"crossref","first-page":"6016","DOI":"10.1182\/blood-2011-12-398958","article-title":"Distinct mutations in STXBP2 are associated with variable clinical presentations in patients with familial hemophagocytic lmphohistiocytosis type 5 (FHL5)","volume":"119","author":"Pagel","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.yexcr.2014.03.014_bib55","doi-asserted-by":"crossref","first-page":"760","DOI":"10.3324\/haematol.2012.073098","article-title":"Development of classical Hodgkin\u05f3s lymphoma in an adult with biallelic STXBP2 mutations","volume":"98","author":"Machaczka","year":"2013","journal-title":"Haematologica"},{"key":"10.1016\/j.yexcr.2014.03.014_bib56","doi-asserted-by":"crossref","first-page":"e14","DOI":"10.1136\/jmg.2005.035253","article-title":"Spectrum and clinical implications of syntaxin 11 gene mutations in familial haemophagocytic lymphohistiocytosis: association with disease-free remissions and haematopoietic malignancies","volume":"43","author":"Rudd","year":"2006","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.yexcr.2014.03.014_bib57","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1002\/pbc.24637","article-title":"Clinical characteristics and outcomes of chediak-Higashi syndrome: a nationwide survey of Japan","volume":"60","author":"Nagai","year":"2013","journal-title":"Pediatr. Blood Cancer"},{"key":"10.1016\/j.yexcr.2014.03.014_bib58","first-page":"135","article-title":"Chediak-Higashi syndrome in a child with Hodgkin\u05f3s disease","volume":"121","author":"Tan","year":"1971","journal-title":"Am. J. Dis. Child."},{"key":"10.1016\/j.yexcr.2014.03.014_bib59","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/gene.2012.3","article-title":"Macrophage activation syndrome as part of systemic juvenile idiopathic arthritis: diagnosis, genetics, pathophysiology and treatment","volume":"13","author":"Ravelli","year":"2012","journal-title":"Genes Immun."},{"key":"10.1016\/j.yexcr.2014.03.014_bib60","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1002\/art.23199","article-title":"Mutations of the hemophagocytic lymphohistiocytosis-associated gene UNC13D in a patient with systemic juvenile idiopathic arthritis","volume":"58","author":"Hazen","year":"2008","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.yexcr.2014.03.014_bib61","doi-asserted-by":"crossref","first-page":"2892","DOI":"10.1002\/art.23734","article-title":"Macrophage activation syndrome in patients with systemic juvenile idiopathic arthritis is associated with MUNC13-4 polymorphisms","volume":"58","author":"Zhang","year":"2008","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.yexcr.2014.03.014_bib62","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1093\/rheumatology\/kep418","article-title":"Mutations in the perforin gene can be linked to macrophage activation syndrome in patients with systemic onset juvenile idiopathic arthritis","volume":"49","author":"Vastert","year":"2010","journal-title":"Rheumatology"},{"key":"10.1016\/j.yexcr.2014.03.014_bib63","doi-asserted-by":"crossref","first-page":"e205","DOI":"10.1097\/MPH.0b013e31827b4859","article-title":"Recurrent macrophage activation syndrome associated with heterozygous perforin W374X gene mutation in a child with systemic juvenile idiopathic arthritis","volume":"35","author":"Unal","year":"2013","journal-title":"J. Pediatr.Hematol. Oncol."},{"key":"10.1016\/j.yexcr.2014.03.014_bib64","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.2337\/db07-0947","article-title":"Variations of the perforin gene in patients with type 1 diabetes","volume":"57","author":"Orilieri","year":"2008","journal-title":"Diabetes"},{"key":"10.1016\/j.yexcr.2014.03.014_bib65","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1038\/gene.2008.35","article-title":"Variations of the perforin gene in patients with multiple sclerosis","volume":"9","author":"Cappellano","year":"2008","journal-title":"Genes Immun."},{"key":"10.1016\/j.yexcr.2014.03.014_bib66","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1111\/j.1365-2141.2007.06922.x","article-title":"Frequency and spectrum of central nervous system involvement in 193 children with haemophagocytic lymphohistiocytosis","volume":"140","author":"Horne","year":"2008","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.yexcr.2014.03.014_bib67","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1212\/WNL.0b013e31824f800a","article-title":"CNS involvement at the onset of primary hemophagocytic lymphohistiocytosis","volume":"78","author":"Deiva","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.yexcr.2014.03.014_bib68","doi-asserted-by":"crossref","first-page":"2658","DOI":"10.1182\/blood-2004-09-3590","article-title":"Severe and progressive encephalitis as a presenting manifestation of a novel missense perforin mutation and impaired cytolytic activity","volume":"105","author":"Feldmann","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.yexcr.2014.03.014_bib69","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s00381-008-0744-z","article-title":"Diagnostic challenges in a child with familial hemophagocytic lymphohistiocytosis type 3 (FHLH3) presenting with fulminant neurological disease","volume":"25","author":"Weisfeld-Adams","year":"2009","journal-title":"Childs Nerv. Syst."},{"key":"10.1016\/j.yexcr.2014.03.014_bib70","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1002\/art.22442","article-title":"Primary necrotizing lymphocytic central nervous system vasculitis due to perforin deficiency in a four-year-old girl","volume":"56","author":"Moshous","year":"2007","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.yexcr.2014.03.014_bib71","doi-asserted-by":"crossref","DOI":"10.3324\/haematol.2010.029389","article-title":"Atypical familial hemophagocytic lymphohistiocytosis due to mutations in UNC13D and STXBP2 overlaps with primary immunodeficiency diseases","author":"Rohr","year":"2010","journal-title":"Haematologica"},{"key":"10.1016\/j.yexcr.2014.03.014_bib72","doi-asserted-by":"crossref","first-page":"5783","DOI":"10.1182\/blood-2011-07-369090","article-title":"Familial hemophagocytic lymphohistiocytosis type 3 (FHL3) caused by deep intronic mutation and inversion in UNC13D","volume":"118","author":"Meeths","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.yexcr.2014.03.014_bib73","doi-asserted-by":"crossref","unstructured":"F. Cichocki, H. Schlums, H. Li, V. Stache, T. Holmes, T.R. Lenvik, S.C.C. Chiang, J.S. Miller, M. Meeths, S.K. Anderson Y.T. Bryceson, Transcriptional regulation of Munc13-4 expression in cytotoxic lymphocytes is disrupted by an intronic mutation associated with a primary immunodeficiency, J. Exp. Med. (2014) in press.","DOI":"10.1084\/jem.20131131"}],"container-title":["Experimental Cell Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001448271400130X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001448271400130X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,8,16]],"date-time":"2020-08-16T23:49:05Z","timestamp":1597621745000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S001448271400130X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7]]},"references-count":73,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,7]]}},"alternative-id":["S001448271400130X"],"URL":"https:\/\/doi.org\/10.1016\/j.yexcr.2014.03.014","relation":{},"ISSN":["0014-4827"],"issn-type":[{"value":"0014-4827","type":"print"}],"subject":[],"published":{"date-parts":[[2014,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pathophysiology and spectrum of diseases caused by defects in lymphocyte cytotoxicity","name":"articletitle","label":"Article Title"},{"value":"Experimental Cell Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yexcr.2014.03.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}